|
|||||
|
|
Changes in health‐related quality of life with treatment of longer‐acting clotting factors: results in the A‐LONG and B‐LONG clinical studies |
|
| Authors: | K. W. Wyrwich S. Krishnan P. Auguste J.‐L. Poon R. von Maltzahn R. Yu G. F. Pierce B. Mei J. Mahlangu S. von Mackensen |
| Affiliation: | 1. Evidera, Bethesda, MD, USA;2. Biogen, Inc., Cambridge, MA, USA;3. Adult Hemophilia Comprehensive Care Unit at University of the Witwatersrand, Faculty of Health Sciences Charlotte Maxeke Johannesburg Hospital, Johannesburg, South Africa;4. Institute of Medical Psychology, University Medical Centre Hamburg‐Eppendorf, Hamburg, Germany |
| Abstract: | |
| Keywords: | haemophilia prophylactic treatment quality of life recombinant factor IX replacement recombinant factor VIII replacement responder definition |